ROCHE IRELAND LIMITED

Roche Ireland Limited is a research-driven healthcare organisation that works to advance science and ensure people have access to the treatments and diagnostics they need today and for generations to come. By combining cutting-edge pharmaceuticals with sophisticated diagnostic tools and digital health solutions, Roche aims to prevent disease, halt its progression and ultimately cure illness, giving patients more time with the people they love.

The company's portfolio spans innovative medicines such as the newly FDA-approved Lunsumio VELO™ for relapsed or refractory follicular lymphoma, alongside a broad range of diagnostic technologies that identify high-risk patients early and enable targeted therapy. Roche's commitment to tackling global health challenges is evident in its focus on cervical-cancer prevention, where it promotes screening access and collaborative research to eliminate the disease.

Based in Ireland and serving patients and healthcare professionals across the island, Roche Ireland delivers value through continuous innovation, trustworthy partnerships and a clear mission to improve health outcomes for all.